Search

everythinglearnresearchcommunity

for

Search:↓

Special cells can help regrow hair in alopecia areata.

Personalized treatments for hair loss focus on specific genetic and biological pathways.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Rigenera® effectively improves hair condition in Androgenetic Alopecia, and HairMetrix® tracks progress well.

Targeting EMT and fibrotic remodeling may help treat androgenetic alopecia.

Stem cell exosomes may help treat hair loss by promoting hair growth.

Stem cell therapy shows promise for treating skin disorders.

Male pattern baldness does not cause an increased risk of prostate cancer.

Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.

Hair aging is caused by stress, hormones, inflammation, and DNA damage affecting hair growth and color.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Moringa seed oil may help prevent hair loss and promote hair growth.

Philippine stingless bee propolis may promote hair growth and fight cancer.

Extracellular vesicles could help treat hair loss by influencing hair growth cycles.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Estrogens and progesterone are key in regulating melasma pigmentation.

The May issue discussed publishing agreements and four studies on cholesterol in hair, cancer cell changes, hormones in the uterus, and skin protein effects.

The document concludes that ongoing medical therapy is crucial for preventing hair loss, and surgical options can restore hair, with future treatments for hair loss being promising.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Finasteride reduces prostate size and PSA levels in young patients.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Gene mutations can cause problems in male genital development.

Hair loss is a common, often overlooked side effect of hormone treatments for breast and prostate cancer.

Hair loss is a common but often unreported side effect of cancer treatments, especially for breast and prostate cancers.

Hair loss is a common side effect of hormone treatments for cancer.

Finasteride for hair loss may increase the risk of certain cancers and has side effects; better regulation and education on its use are needed.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

Urinary PSA could be an early marker for enlarged prostate.